Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
STONULL
- Development stage
- Unknown
- Lead developer
- Krishlar Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
STONULL is an Ayurvedic capsule formulation developed and marketed by Krishlar Pharmaceutical, an Indian pharmaceutical company. It is specifically indicated for the management of urinary calculi (kidney stones) and urinary stones. As a polyherbal Ayurvedic preparation, it is designed to facilitate the breakdown and natural passage of stones through the urinary tract, likely employing traditional lithontriptic and diuretic herbs. The product is administered orally and is marketed within the company's portfolio of herbal and Ayurvedic remedies, alongside other stone-related products such as UROKRIT.
- Brand names
- STONULL
- Other names
- STONULL Capsule
Beyond the preview
Go deeper on STONULL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STONULL.